fficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trial
Project/Area Number |
25861033
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Psychiatric science
|
Research Institution | Fujita Health University |
Principal Investigator |
KISHI Taro 藤田保健衛生大学, 医学部, 講師 (40536801)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 大うつ病性障害 / エスシタロプラム / パロキセチン徐放製剤 / 効果 / 安全性 / 大うつ病性障害と / 無作為割付試験 |
Outline of Final Research Achievements |
We included about one hundred patients with major depressive disorder. Some patients who enter the study have not complete the study. Regarding the interim analysis (not all patients include), there were not significant differences in the outcomes with respect to efficacy and safety between both treatment groups.
|
Report
(3 results)
Research Products
(9 results)